Photo from wikipedia
Guidelines recommend albumin as the plasma‐expander of choice for acute kidney injury (AKI) in cirrhosis. However, the impact of these recommendations on patient outcomes remains unclear. We aimed to determine… Click to show full abstract
Guidelines recommend albumin as the plasma‐expander of choice for acute kidney injury (AKI) in cirrhosis. However, the impact of these recommendations on patient outcomes remains unclear. We aimed to determine the practice‐patterns and outcomes associated with albumin use in a large, nationwide‐US cohort of hospitalized cirrhotics with AKI.
Keywords:
outcomes associated;
kidney injury;
acute kidney;
practice patterns;
patterns outcomes
Journal Title: Liver International
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Liver International
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!